BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38673889)

  • 21. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodal metastasis size predicts disease-free survival in cutaneous head and neck squamous cell carcinoma involving the parotid but not cervical nodes.
    Sood A; Wykes J; McGuinness J; Fowler A; Ebrahimi A
    ANZ J Surg; 2020 Dec; 90(12):2537-2542. PubMed ID: 33176051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
    Richtig G; Aigelsreiter AM; Asslaber M; Weiland T; Pichler M; Eberhard K; Sygulla S; Schauer S; Hoefler G; Aigelsreiter A
    Histopathology; 2019 Jul; 75(1):118-127. PubMed ID: 30861166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
    Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
    Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Podoplanin expression in cutaneous squamous cell carcinomas and its relationship to histopathological prognostic factors.
    Gülseren D; Gököz Ö; Karahan S; Karaduman A
    J Histotechnol; 2020 Sep; 43(3):147-152. PubMed ID: 32496961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma.
    Solares CA; Boyle GM; Brown I; Parsons PG; Panizza B
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3 Suppl 1):S15-9. PubMed ID: 20176274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR expression in advanced head and neck cutaneous squamous cell carcinoma.
    Sweeny L; Dean NR; Magnuson JS; Carroll WR; Helman EE; Hyde SO; Desmond RL; Rosenthal EL
    Head Neck; 2012 May; 34(5):681-6. PubMed ID: 21739514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21{Waf1/CIP1} is a poor diagnostic and prognostic marker for OSCC although its expression increases in patients with N1 regional metastasis.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Iruegas EP; de Almeida MR; Barros-Angueira F; Torreira MG; García-García A
    Cancer Biomark; 2015; 15(1):19-26. PubMed ID: 25524938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
    Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
    Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
    Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
    Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
    Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
    Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.